Correlation Between Genovate Biotechnology and GrandTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genovate Biotechnology and GrandTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genovate Biotechnology and GrandTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genovate Biotechnology Co and GrandTech CG Systems, you can compare the effects of market volatilities on Genovate Biotechnology and GrandTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genovate Biotechnology with a short position of GrandTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genovate Biotechnology and GrandTech.

Diversification Opportunities for Genovate Biotechnology and GrandTech

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Genovate and GrandTech is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Genovate Biotechnology Co and GrandTech CG Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GrandTech CG Systems and Genovate Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genovate Biotechnology Co are associated (or correlated) with GrandTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GrandTech CG Systems has no effect on the direction of Genovate Biotechnology i.e., Genovate Biotechnology and GrandTech go up and down completely randomly.

Pair Corralation between Genovate Biotechnology and GrandTech

Assuming the 90 days trading horizon Genovate Biotechnology Co is expected to generate 0.45 times more return on investment than GrandTech. However, Genovate Biotechnology Co is 2.23 times less risky than GrandTech. It trades about -0.31 of its potential returns per unit of risk. GrandTech CG Systems is currently generating about -0.27 per unit of risk. If you would invest  2,245  in Genovate Biotechnology Co on August 30, 2024 and sell it today you would lose (75.00) from holding Genovate Biotechnology Co or give up 3.34% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Genovate Biotechnology Co  vs.  GrandTech CG Systems

 Performance 
       Timeline  
Genovate Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genovate Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Genovate Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
GrandTech CG Systems 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GrandTech CG Systems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Genovate Biotechnology and GrandTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genovate Biotechnology and GrandTech

The main advantage of trading using opposite Genovate Biotechnology and GrandTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genovate Biotechnology position performs unexpectedly, GrandTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GrandTech will offset losses from the drop in GrandTech's long position.
The idea behind Genovate Biotechnology Co and GrandTech CG Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
CEOs Directory
Screen CEOs from public companies around the world
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios